Long-Term Biodistribution and Safety Profile of Laser-Generated Gold Nanoparticles Following High-Dose Administration in Mice
4 affiliations
- 1Ministry of Health of the Russian Federation , , ,
- 2Kurnakov Institute of General and Inorganic Chemistry of the Russian Academy of Sciences (IGIC RAS) , ,
- 3National Research Nuclear University MEPhI (Moscow Engineering Physics Institute) , ,
- 4Aix-Marseille University , , ,
Abstract
Gold nanoparticles (AuNPs) have emerged as versatile agents for a wide range of biomedical applications, including imaging, diagnostics, and therapy. While their use in modalities such as CT imaging and radiotherapy is particularly promising, these applications require high systemic doses (≥500 mg Au/kg), necessitating thorough evaluation of long-term biodistribution and safety profiles. Here, we present a comprehensive one-year assessment of Polyethylene glycol (PEG) -coated laser-synthesized AuNPs (mean core diameter ∼8 nm). After intravenous administration at a high dose, biodistribution was evaluated in healthy mice (n = 8; 874 ± 56 mg Au/kg) using a serial CT imaging, with terminal ICP-AES validation, blood biochemistry, and histology performed in 5 of these animals. AuNPs exhibited prolonged blood circulation (half-life 21 ± 3 h) and accumulated predominantly in reticuloendothelial organs: 42.2 ± 3.6%ID/cm3 in the liver and 40.2 ± 3.3%ID/cm3 in the spleen, with one-year retention of 77.5% and 83.1%, respectively. Despite substantial hepatic and splenic retention, no histopathological changes were detected in any major organs, including kidney and liver. Serum biochemical markers of liver, kidney, and pancreatic function revealed no statistically significant differences between the treated and control groups. Only a slight elevation in aspartate aminotransferase (AST) was observed in two treated animals (184.1 and 187.8 U/L vs 118.3 ± 18.4 U/L in the control group), while all other liver function markers (ALT, alkaline phosphatase, bilirubin) remained unaltered. Additionally, tumor uptake was evaluated in two separate cohorts of mice bearing subcutaneous tumor models, mammary adenocarcinoma Ca755 (n = 3, 809 ± 28 mg Au/kg) and melanoma B16F10 (n = 3, 814 ± 45 mg Au/kg). AuNPs accumulated in tumor tissue, reaching 9.4 ± 1.9%ID/cm3 for Ca755 and 5.3 ± 1.1%ID/cm3 for B16F10. Overall, these results provide insight into the safety profile and tumor uptake of laser-synthesized AuNPs, supporting their potential as a platform for novel radiosensitizers and contrast agents.
Related
- Selective Blood Cell Hitchhiking in Whole Blood With Ionic Liquid‐Coated PLGA Nanoparticles to Redirect Biodistribution After Intravenous Injection
- Influence of PEGylation and Surface Charge on Biodistribution of Shortwave Infrared Emitting Nanoparticles for In Vivo Bioimaging
- Detection of Tiludronic Acid in Equine Hair and Its Segmental Analysis Following Administration
- LC-ESI/MS/MS profile of purslane (Portulaca oleracea) nanoparticles for reduction foodborne pathogens and enhancing quality parameters of guava nectar model
- Magnetic Particle Imaging Reveals Heterogeneous Retention, Leakage, and Redistribution of Nanoparticles Following Intratumoral Injection
BibTeX
@article{finogenova2026longterm,
title = {{Long-Term Biodistribution and Safety Profile of Laser-Generated Gold Nanoparticles Following High-Dose Administration in Mice}},
author = {Yulia A. Finogenova and Vsevolod A. Skribitsky and Alexey A. Lipengolts and Natalia V. Pozdniakova and Kristina E. Shpakova and Gleb V. Tikhonowski and Anton A. Kasianov and Anton A. Popov and Anna V. Smirnova and Sergey M. Klimentov and Andrei V. Kabashin and Elena Y. Grigorieva},
journal = {ACS Omega},
year = {2026},
month = nov,
doi = {10.1021/acsomega.5c11816},
url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.5c11816/5464907/Long-Term-Biodistribution-and-Safety-Profile-of},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Long-Term Biodistribution and Safety Profile of Laser-Generated Gold Nanoparticles Following High-Dose Administration in Mice
AU - Yulia A. Finogenova
AU - Vsevolod A. Skribitsky
AU - Alexey A. Lipengolts
AU - Natalia V. Pozdniakova
AU - Kristina E. Shpakova
AU - Gleb V. Tikhonowski
AU - Anton A. Kasianov
AU - Anton A. Popov
AU - Anna V. Smirnova
AU - Sergey M. Klimentov
AU - Andrei V. Kabashin
AU - Elena Y. Grigorieva
PY - 2026
DA - 2026/11/05
JO - ACS Omega
DO - 10.1021/acsomega.5c11816
UR - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.5c11816/5464907/Long-Term-Biodistribution-and-Safety-Profile-of
AB - Gold nanoparticles (AuNPs) have emerged as versatile agents for a wide range of biomedical applications, including imaging, diagnostics, and therapy. While their use in modalities such as CT imaging and radiotherapy is particularly promising, these applications require high systemic doses (≥500 mg Au/kg), necessitating thorough evaluation of long-term biodistribution and safety profiles. Here, we present a comprehensive one-year assessment of Polyethylene glycol (PEG) -coated laser-synthesized AuNPs (mean core diameter ∼8 nm). After intravenous administration at a high dose, biodistribution was evaluated in healthy mice (n = 8; 874 ± 56 mg Au/kg) using a serial CT imaging, with terminal ICP-AES validation, blood biochemistry, and histology performed in 5 of these animals. AuNPs exhibited prolonged blood circulation (half-life 21 ± 3 h) and accumulated predominantly in reticuloendothelial organs: 42.2 ± 3.6%ID/cm3 in the liver and 40.2 ± 3.3%ID/cm3 in the spleen, with one-year retention of 77.5% and 83.1%, respectively. Despite substantial hepatic and splenic retention, no histopathological changes were detected in any major organs, including kidney and liver. Serum biochemical markers of liver, kidney, and pancreatic function revealed no statistically significant differences between the treated and control groups. Only a slight elevation in aspartate aminotransferase (AST) was observed in two treated animals (184.1 and 187.8 U/L vs 118.3 ± 18.4 U/L in the control group), while all other liver function markers (ALT, alkaline phosphatase, bilirubin) remained unaltered. Additionally, tumor uptake was evaluated in two separate cohorts of mice bearing subcutaneous tumor models, mammary adenocarcinoma Ca755 (n = 3, 809 ± 28 mg Au/kg) and melanoma B16F10 (n = 3, 814 ± 45 mg Au/kg). AuNPs accumulated in tumor tissue, reaching 9.4 ± 1.9%ID/cm3 for Ca755 and 5.3 ± 1.1%ID/cm3 for B16F10. Overall, these results provide insight into the safety profile and tumor uptake of laser-synthesized AuNPs, supporting their potential as a platform for novel radiosensitizers and contrast agents.
SN - 2470-1343
ER -